Literature DB >> 23529845

PAX5 alteration-associated gene-expression signatures in B-cell acute lymphoblastic leukemia.

Zhen Shang1, Yuechao Zhao, Kuangguo Zhou, Yanling Xu, Wei Huang.   

Abstract

The paired box domain gene 5 (PAX5) is frequently altered in both childhood and adult B-cell acute lymphoblastic leukemia, and takes part in leukemogenesis. We analyzed data from the database of Gene Expression Omnibus (accession number: GSE11877) using bioinformatical and statistical methods. The results showed that cases of PAX5 alteration can cluster using unsupervised clustering algorithms, and one gene, zinc and ring finger 1 (ZNRF1), was characterized and validated by quantitative RT-PCR. ZNRF1 may be associated with leukemogenesis of ALL with PAX5 alteration.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23529845     DOI: 10.1007/s12185-013-1309-9

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  20 in total

1.  The VHL tumor suppressor: riding tandem with GSK3beta in primary cilium maintenance.

Authors:  Claudio R Thoma; Ian J Frew; Wilhelm Krek
Journal:  Cell Cycle       Date:  2007-05-25       Impact factor: 4.534

2.  Pathways through relapses and deaths of children with acute lymphoblastic leukemia: role of allogeneic stem-cell transplantation in Nordic data.

Authors:  Ulla M Saarinen-Pihkala; Carsten Heilmann; Jacek Winiarski; Anders Glomstein; Jonas Abrahamsson; Johan Arvidson; Albert N Békássy; Erik Forestier; Gudmundur Jonmundsson; Henrik Schroeder; Kim Vettenranta; Finn Wesenberg; Göran Gustafsson
Journal:  J Clin Oncol       Date:  2006-12-20       Impact factor: 44.544

3.  ZNRF1 interacts with tubulin and regulates cell morphogenesis.

Authors:  Koichi Yoshida; Masashi Watanabe; Shigetsugu Hatakeyama
Journal:  Biochem Biophys Res Commun       Date:  2009-09-06       Impact factor: 3.575

4.  ZNRF1 promotes Wallerian degeneration by degrading AKT to induce GSK3B-dependent CRMP2 phosphorylation.

Authors:  Shuji Wakatsuki; Fuminori Saitoh; Toshiyuki Araki
Journal:  Nat Cell Biol       Date:  2011-11-06       Impact factor: 28.824

Review 5.  Centrosome amplification in tumorigenesis.

Authors:  Simon J Anderhub; Alwin Krämer; Bettina Maier
Journal:  Cancer Lett       Date:  2012-02-14       Impact factor: 8.679

6.  Epigenetic inactivation of paired box gene 5, a novel tumor suppressor gene, through direct upregulation of p53 is associated with prognosis in gastric cancer patients.

Authors:  X Li; K F Cheung; X Ma; L Tian; J Zhao; M Y Y Go; B Shen; A S L Cheng; J Ying; Q Tao; J J Y Sung; H-F Kung; J Yu
Journal:  Oncogene       Date:  2011-11-21       Impact factor: 9.867

7.  PAX5 deletion is common and concurrently occurs with CDKN2A deletion in B-lineage acute lymphoblastic leukemia.

Authors:  Miyoung Kim; Jung Eun Choi; Cha Ja She; Sang Mee Hwang; Hee Young Shin; Hyo Seop Ahn; Sung-Soo Yoon; Byoung Kook Kim; Myoung Hee Park; Dong Soon Lee
Journal:  Blood Cells Mol Dis       Date:  2011-05-05       Impact factor: 3.039

8.  VHL loss causes spindle misorientation and chromosome instability.

Authors:  Claudio R Thoma; Alberto Toso; Katrin L Gutbrodt; Sabina P Reggi; Ian J Frew; Peter Schraml; Alexander Hergovich; Holger Moch; Patrick Meraldi; Wilhelm Krek
Journal:  Nat Cell Biol       Date:  2009-07-20       Impact factor: 28.824

9.  Proteasomal degradation of glutamine synthetase regulates schwann cell differentiation.

Authors:  Fuminori Saitoh; Toshiyuki Araki
Journal:  J Neurosci       Date:  2010-01-27       Impact factor: 6.167

10.  Akt: a double-edged sword in cell proliferation and genome stability.

Authors:  Naihan Xu; Yuanzhi Lao; Yaou Zhang; David A Gillespie
Journal:  J Oncol       Date:  2012-03-15       Impact factor: 4.375

View more
  1 in total

1.  The Expression and Effection of MicroRNA-499a in High-Tobacco Exposed Head and Neck Squamous Cell Carcinoma: A Bioinformatic Analysis.

Authors:  Shi-Qi Gong; Meng Xu; Ming-Liang Xiang; Ya-Min Shan; Hao Zhang
Journal:  Front Oncol       Date:  2019-07-31       Impact factor: 6.244

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.